Benitec Biopharma Inc. (BNTC) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 |
|---|
| Total Current Assets | 186.02M | 189.59M | 95.08M | 98.52M | 104.01M | 78.71M | 68.33M | 51.67M | 14.37M | 20.8M | 26.41M | 3.73M | 7.39M | 10.97M | 17.08M | 4.82M | 8.84M | 12.67M | 16.37M | 20.61M |
| Cash & Short-Term Investments | 184.76M | 188.79M | 94.48M | 97.74M | 103.58M | 78.28M | 67.84M | 50.87M | 14.14M | 20.37M | 25.86M | 2.48M | 6.55M | 10.54M | 16.53M | 4.06M | 8.63M | 12.33M | 15.73M | 19.77M |
| Cash Only | 184.76M | 188.79M | 94.48M | 97.74M | 103.58M | 78.28M | 67.84M | 50.87M | 14.14M | 20.37M | 25.86M | 2.48M | 6.55M | 10.54M | 16.53M | 4.06M | 8.63M | 12.33M | 15.73M | 19.77M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3K | 130K | 7K | 33K | 3K | 2K | 4K | 229K | 53K | 53K | 53K | 55K | 56K | 68K | 3K | 3K | 5K | 5K | 3K | 25K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | 721.5 | 103.33 | 233.29 | - | - | 9.38 | 14.72 | - | 796.25 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.25M | 675K | 593K | 741K | 424K | 428K | 490K | 579K | 13K | 369K | 13K | 13K | 788K | 14K | 13K | 14K | 0 | 0 | 0 | 15K |
| Total Non-Current Assets | 983K | 1.09M | 948K | 1.07M | 1.2M | 355K | 439K | 536K | 633K | 527K | 641K | 735K | 825K | 930K | 1.03M | 1.15M | 1.22M | 1.34M | 1.46M | 771K |
| Property, Plant & Equipment | 916K | 1.02M | 873K | 991K | 1.11M | 288K | 358K | 449K | 539K | 451K | 531K | 613K | 695K | 789K | 890K | 993K | 1.04M | 1.16M | 1.27M | 577K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | 0.01x | 0.07x | 0.02x | - | - | 0.04x | 0.02x | - | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 67K | 66K | 75K | 83K | 90K | 67K | 81K | 87K | 94K | 76K | 110K | 122K | 130K | 141K | 144K | 160K | 181K | 186K | 194K | 194K |
| Total Assets | 187M | 190.68M | 96.03M | 99.59M | 105.21M | 79.07M | 68.77M | 52.21M | 15M | 21.35M | 27.05M | 4.46M | 8.22M | 11.9M | 18.11M | 5.97M | 10.06M | 14.01M | 17.84M | 21.38M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | 0.00x | 0.01x | 0.00x | - | - | 0.00x | 0.00x | - | 0.00x |
| Asset Growth % | 77.74% | 141.16% | 39.63% | 90.75% | 601.44% | 270.29% | 154.22% | 1069.58% | 82.47% | 79.36% | 49.34% | -25.26% | -18.32% | -15.05% | 1.56% | -72.06% | -25.05% | -9.66% | 100.04% | 84.51% |
| Total Current Liabilities | 3.27M | 2.8M | 2.02M | 1.8M | 7.03M | 3.09M | 4.55M | 4.92M | 3.44M | 5.75M | 4.53M | 3.98M | 3.15M | 2.49M | 3.01M | 2.53M | 1.91M | 2.48M | 1.6M | 1.37M |
| Accounts Payable | 635K | 1.02M | 271K | 201K | 433K | 593K | 903K | 1.35M | 815K | 2.62M | 1.53M | 1.14M | 635K | 531K | 608K | 422K | 100K | 682K | 323K | 274K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | -52.08K | 190.76K | -1.16K | - | - | - | - | 2.64K | - | - | - | 87.09K |
| Short-Term Debt | 482K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.16M | 483K | 463K | 426K | 426K | 537K | 495K | 475K | 1.66M | 523K | 2.15M | 1.82M | 429K | 396K | 385K | 400K | 357K | 321K | 301K | 276K |
| Current Ratio | 56.82x | 67.69x | 46.95x | 54.67x | 14.80x | 25.48x | 15.01x | 10.49x | 4.18x | 3.62x | 5.83x | 0.94x | 2.35x | 4.41x | 5.67x | 1.90x | 4.63x | 5.11x | 10.23x | 15.05x |
| Quick Ratio | 56.82x | 67.69x | 46.95x | 54.67x | 14.80x | 25.48x | 15.01x | 10.49x | 4.18x | 3.62x | 5.83x | 0.94x | 2.35x | 4.41x | 5.67x | 1.90x | 4.63x | 5.11x | 10.23x | 15.05x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 394K | 519K | 403K | 495K | 613K | 38K | 41K | 38K | 62K | 137K | 211K | 284K | 354K | 422K | 491K | 559K | 635K | 698K | 760K | 0 |
| Long-Term Debt | 394K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 519K | 403K | 495K | 613K | 0 | 0 | 0 | 62K | 137K | 211K | 284K | 354K | 422K | 491K | 559K | 635K | 698K | 760K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 38K | 41K | 38K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 3.67M | 3.32M | 2.43M | 2.3M | 7.64M | 3.13M | 4.59M | 4.96M | 3.5M | 5.88M | 4.75M | 4.26M | 3.51M | 2.91M | 3.5M | 3.09M | 2.54M | 3.18M | 2.36M | 1.37M |
| Total Debt | 876K | 987K | 817K | 849K | 959K | 137K | 211K | 284K | 354K | 423K | 491K | 559K | 623K | 685K | 749K | 811K | 867K | 911K | 954K | 213K |
| Net Debt | -183.88M | -187.8M | -93.66M | -96.89M | -102.62M | -78.15M | -67.63M | -50.58M | -13.79M | -19.95M | -25.37M | -1.92M | -5.93M | -9.85M | -15.79M | -3.25M | -7.76M | -11.42M | -14.77M | -19.56M |
| Debt / Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | 0.01x | 0.03x | 0.03x | 0.02x | 2.77x | 0.13x | 0.08x | 0.05x | 0.28x | 0.12x | 0.08x | 0.06x | 0.01x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | -1035.25x | -1132.00x | -979.00x | -581.63x | -627.14x | -600.22x | -564.89x | -505.70x | -326.50x | -437.27x | -5044.00x | -3855.00x |
| Total Equity | 183.33M | 187.36M | 93.6M | 97.3M | 97.57M | 75.94M | 64.18M | 47.25M | 11.5M | 15.47M | 22.31M | 202K | 4.71M | 8.99M | 14.61M | 2.88M | 7.52M | 10.84M | 15.47M | 20.01M |
| Equity Growth % | 87.9% | 146.72% | 45.84% | 105.92% | 748.43% | 390.89% | 187.7% | 23290.1% | 144.01% | 72% | 52.66% | -92.99% | -37.33% | -17% | -5.57% | -85.6% | -31.2% | -25.91% | 100.04% | 95.45% |
| Book Value per Share | 3.71 | 4.08 | 2.25 | 2.69 | 2.53 | 3.44 | 6.03 | 4.68 | 1.10 | 1.50 | 2.59 | 0.03 | 2.86 | 1.39 | 5.72 | 1.50 | 3.91 | 5.64 | 8.05 | 12.05 |
| Total Shareholders' Equity | 183.33M | 187.36M | 93.6M | 97.3M | 97.57M | 75.94M | 64.18M | 47.25M | 11.5M | 15.47M | 22.31M | 202K | 4.71M | 8.99M | 14.61M | 2.88M | 7.52M | 10.84M | 15.47M | 20.01M |
| Common Stock | 3K | 3K | 2K | 2K | 2K | 2K | 1K | 1K | 0 | 0 | 0 | 0 | 3K | 3K | 3K | 0 | 1K | 1K | 1K | 1K |
| Retained Earnings | -260.91M | -248.98M | -237.14M | -228.18M | -212.03M | -202.68M | -195.32M | -190.26M | -184.92M | -180.64M | -173.84M | -167.89M | -163.23M | -158.83M | -153.42M | -148.33M | -143.26M | -139.99M | -135.16M | -130.12M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -952K | -883K | -750K | -839K | -716K | -688K | -993K | -892K | -835K | -952K | -780K | -830K | -853K | -898K | -738K | -1.25M | -1.51M | -1.27M | -1.22M | -1.46M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |